Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicament for treating chronic hepatitis

A technology for chronic hepatitis and medicine, applied in the field of processing and preparation of traditional Chinese medicine, can solve the problems of poor treatment effect, monotonous formula, single function, etc., and achieve the effects of convenient taking, reasonable formula and good treatment effect.

Inactive Publication Date: 2010-06-16
王宏钊
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, the number of domestically produced Chinese patent medicines has increased, but due to their monotonous and unreasonable formulas, they still have the defects of single function and poor therapeutic effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: A medicine for treating chronic hepatitis, containing the following components in parts by weight: 30-60 parts of Radix Pseudostellariae, 20-50 parts of Ganoderma lucidum, 20-50 parts of Citrus aurantium, 30-60 parts of Gallus gallis 60 parts, 30-100 parts of dandelion, 30-60 parts of hawthorn, 40-60 parts of schisandra, 20-40 parts of astragalus, 20-45 parts of phylloxera, 20-90 parts of licorice, 25-75 parts of honeysuckle, 30-30 parts of angelica 45 parts, 30-70 parts of tangerine peel.

[0032] The components are dried, ground and pulverized together, and passed through a 100-mesh sieve to prepare the required pharmaceutical dosage form. The pharmaceutical dosage form is powder, or tablet, or pill, or granule, or capsule.

Embodiment 2

[0033] Example 2: The preparation method of the drug in this example is the same as in Example 1, and the similarities will not be repeated. The difference is: 30 parts of Radix Pseudostellariae, 20 parts of Ganoderma lucidum, 20 parts of Citrus aurantium, 30 parts of Gallus gallis, and Dandelion 30 parts, 30 parts of hawthorn, 40 parts of schisandra, 20 parts of astragalus, 20 parts of phylloxera, 20 parts of licorice, 25 parts of honeysuckle, 30 parts of angelica, and 30 parts of tangerine peel.

Embodiment 3

[0034] Embodiment 3: The preparation method of the medicine of this embodiment is the same as that of Example 1, and the similarities will not be repeated. The difference is that a kind of medicine for the treatment of chronic hepatitis contains the following components in parts by weight: Radix Pseudostellariae 60 parts, 50 parts of Ganoderma lucidum, 50 parts of Citrus aurantium, 60 parts of Gallus chinensis, 100 parts of dandelion, 60 parts of hawthorn, 60 parts of Schisandra chinensis, 40 parts of astragalus, 45 parts of phylloxera, 90 parts of licorice, 75 parts of honeysuckle, angelica 45 parts, 70 parts of tangerine peel.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating chronic hepatitis, which comprises the following components in part by weight: 30 to 60 parts of heterophylly falsestarwort root, 20 to 50 parts of glossy ganoderma, 20 to 50 parts of hovenia dulcis, 30 to 60 parts of chicken's gizzard-membrane, 30 to 100 parts of mongolian dandelion herb, 30 to 60 parts of hawthorn fruit, 40 to 60 parts of shizandra berry, 20 to 40 parts of astragalus, 20 to 45 parts of common leafflower herb, 20 to 90 parts of liquoric root, 25 to 75 parts of honeysuckle, 30 to 45 parts of Chinese angelica and 30 to 70 parts of tangerine peel. Based on Chinese medicinal and pharmacologic theory, through years of clinical practice, the medicament for treating the chronic hepatitis is prepared from pure Chinese medicaments which are selected from Chinese medical treasury and have the effects of clearing away heat and toxic materials, eliminating stagnation and removing blood stasis, promoting blood circulation and regulating qi, activating immunity and inhibiting virus, has the good treatment effect on various kinds of acute and chronic hepatitis, and also has the good treatment effect on early liver cirrhosis ascites. The effective rate of the medicament can reach 93.3 percent through clinical statistics.

Description

1. Technical field: [0001] The invention relates to a medicine, in particular to a Chinese herbal medicine for treating chronic hepatitis, and belongs to the field of processing and preparation of traditional Chinese medicines. 2. Background technology: [0002] The liver is located in the upper abdomen, below the diaphragm. The liver is the largest gland in the human body and has many important functions. There are many reasons for hepatitis, including genetics, environment, diet, drugs, viral infections, etc., as well as smoking, excessive drinking, and excessive fatigue. [0003] At present, although there are many drugs for the treatment of chronic hepatitis, most of them have mediocre curative effect and small scope of application. Imported western medicines are not only expensive, but also have unsatisfactory curative effects, and have certain toxic and side effects. In recent years, the number of domestically produced Chinese patent medicines has increased, but due...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/752A61P1/16A61P31/14A61P31/20A61K35/37A61K35/57
Inventor 王宏钊
Owner 王宏钊
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products